May 26, 2026
By Vanguard with the work of Anu Bradford, Robert J. Jackson Jr., Mary Schapiro, Michael Porter, and Aswath Damodaran.

The Return of the Strategic Deal

Cross-border dealmaking is returning, but it is not returning to the world that preceded the last cycle. The next phase of international M&A will be more selective, more regulated, more politically exposed, and more dependent on execution discipline than the expansionary cycles that came before it.

After several years of uneven activity, the global M&A market entered 2026 with renewed momentum. Financing conditions had stabilized in many markets, corporate portfolios were being reassessed, and strategic buyers were again looking beyond domestic markets for growth, capabilities, technology, infrastructure, and supply-chain resilience. S&P Global Market Intelligence reported that announced global M&A volume reached $861.1 billion in the first quarter of 2026, the strongest start since 2021, even as the number of announced deals declined sharply. Reuters similarly reported that global M&A activity exceeded $1.2 trillion in the first quarter of 2026, with deal value rising despite a decline in deal volume and cross-border M&A rising significantly.

The signal is important. Companies are not retreating from transactions. They are becoming more selective. The market is rewarding high-conviction deals, large strategic moves, and transactions tied to clear transformation logic. At the same time, smaller and less certain transactions remain harder to execute. Deal flow is not broad-based. It is concentrated around assets that solve strategic problems: technology access, market entry, energy security, industrial capacity, critical minerals, defense capability, data infrastructure, supply-chain diversification, and portfolio repositioning.

This is not a conventional M&A recovery. It is a disciplined recovery under scrutiny.

For executives and boards, the implication is clear. Cross-border M&A can still be a powerful growth tool, but the bar is higher. Acquirers must prove not only that a target is attractive, but that the transaction can survive regulatory review, justify its valuation, integrate across cultures and jurisdictions, and strengthen the enterprise under volatile conditions.

Why Cross-Border Deals Are Harder Now

Cross-border transactions have always carried complexity. Currency risk, foreign law, tax planning, labor regulation, cultural integration, political relationships, and execution distance have long made international deals more difficult than domestic ones. What has changed is the number of institutions now involved in determining whether a transaction can proceed and whether it will create value.

The first source of complexity is national security review. Governments are scrutinizing foreign investment in sectors once treated as commercially ordinary but now viewed as strategically sensitive. Semiconductors, artificial intelligence, cloud infrastructure, data centers, telecommunications, defense technologies, critical minerals, energy systems, ports, logistics, biotechnology, and digital platforms can all attract attention. Ownership, access rights, data flows, supply-chain dependencies, and foreign influence are now part of the review.

The second source is competition law. Antitrust authorities are more skeptical of consolidation in concentrated markets, digital ecosystems, healthcare, grocery, labor-intensive sectors, and industries where data or platform access may create durable advantage. A deal that appears manageable from a financial perspective may still face lengthy review if regulators believe it reduces innovation, strengthens gatekeeping power, harms workers, or limits customer choice.

The third source is geopolitical fragmentation. Deals are evaluated against national priorities. A transaction involving strategic technology may be viewed differently in Washington, Brussels, London, Beijing, New Delhi, Riyadh, or Tokyo. The same asset can be seen as a growth opportunity, a supply-chain vulnerability, a national champion, or a security risk depending on the jurisdiction.

The fourth source is valuation uncertainty. Buyers and sellers continue to face gaps in expectations. Sellers often anchor to prior peak multiples. Buyers price higher rates, currency volatility, margin pressure, regulatory delay, integration risk, and uncertain exit environments. Financing may be more available than in the most constrained periods, but the cost of capital still requires greater discipline.

The fifth source is post-deal integration. Cross-border deals increasingly involve culturally, technologically, and regulatorily complex assets. Integrating a software company across data regimes, a manufacturing asset across labor systems, or an infrastructure platform across national security commitments requires far more than operational coordination.

The result is that the real question in cross-border M&A is not simply “Can we buy it?” It is “Can we own it well?”

The New Deal Thesis

The strongest cross-border transactions in 2026 are built around strategic necessity rather than geographic ambition.

In earlier cycles, international expansion often rested on broad market-access logic. A company wanted presence in Asia, Latin America, Europe, or the Middle East. It bought a local player, added scale, and expected growth to follow. That logic still exists, but it is less sufficient. In a fragmented global economy, presence alone does not justify complexity.

A modern cross-border deal thesis should answer five questions.

First, what strategic problem does the transaction solve? The best deals give the buyer something difficult to build organically: technology, regulatory access, local distribution, manufacturing capacity, customer relationships, resource security, talent, data, infrastructure, or brand position.

Second, why is acquisition better than partnership, minority investment, joint venture, licensing, or organic build? Cross-border ownership is the most complex form of entry. It should be chosen because control is necessary, not because acquisition is familiar.

Third, what regulatory objections are likely? A serious deal thesis includes national security, antitrust, data, sanctions, foreign investment, labor, and sector-specific review from the start. These are not legal footnotes. They are transaction design variables.

Fourth, what assumptions drive valuation? Revenue synergies, cost savings, tax efficiencies, cross-selling, technology integration, and market expansion should be stress-tested under multiple scenarios. If the deal only works under optimistic assumptions, it is not disciplined.

Fifth, what must be true after closing? A transaction should define the few integration outcomes that matter most. These may include retaining key talent, preserving licenses, meeting regulatory commitments, protecting customer relationships, maintaining local management credibility, integrating data systems, or achieving procurement synergies.

A deal thesis that cannot answer these questions is not ready for board approval.

National Security as a Core Deal Variable

National security review has moved from the edge of transaction planning to the center. In the United States, CFIUS remains one of the most important foreign investment review mechanisms, but the broader trend is global. Many countries have expanded or strengthened screening regimes to review transactions involving critical infrastructure, sensitive technology, data, defense, energy, healthcare, media, and strategic resources.

This creates a fundamental change in deal strategy. Acquirers can no longer assume that national security review is relevant only to defense contractors or obvious military technologies. Digital infrastructure, AI models, cloud capacity, identity systems, subsea cables, geolocation data, critical minerals, and advanced manufacturing can all raise security questions. Reuters legal analysis has described national security law in 2026 as increasingly focused on defense-tech investment, critical minerals, digital infrastructure, and extraterritorial controls.

The practical implication is that national security assessment should begin before signing, not after filing.

Buyers should ask who will control the asset, where sensitive data will reside, which governments may view the asset as strategic, whether foreign ownership creates concern, whether mitigation agreements may be required, and whether operational commitments could reduce the value of the deal. A mitigation requirement that limits data access, restricts governance rights, requires local security officers, mandates local facilities, or imposes reporting obligations can change the economics of ownership.

Sellers should also prepare. A target in a sensitive sector may need to understand which bidders are viable before running a process. The highest price may not come from the most approvable buyer. In a heightened scrutiny era, certainty of closing can be as valuable as headline valuation.

Boards should therefore treat regulatory approvability as part of deal value. A lower bid from a buyer with a credible approval path may be superior to a higher bid that cannot close.

The Valuation Discipline Gap

Valuation remains one of the central challenges in cross-border M&A. The market is active, but not indiscriminate. Large strategic deals are moving, while smaller transactions remain more subdued. McKinsey has noted that global M&A activity increased meaningfully in 2025 but remained below long-term historical averages as a share of market value, suggesting room for growth but not a full return to earlier cycle conditions. KPMG likewise described the 2026 M&A recovery as unfolding in a more complex environment shaped by geopolitical fragmentation, regulatory volatility, shifting tax policy, and technological change.

This creates a valuation discipline gap. Sellers often price assets based on scarcity, strategic relevance, or prior-cycle multiples. Buyers must price closing risk, integration risk, financing conditions, currency volatility, regulatory remedies, and uncertain growth assumptions. The difference between these perspectives can stall deals or produce weak acquisitions.

Acquirers need a more rigorous valuation model for cross-border targets. The model should include not only base-case financial projections but also risk-adjusted costs of delay, remedy requirements, integration investment, tax leakage, working-capital needs, local financing costs, foreign-exchange exposure, and management retention.

The most common valuation mistake is overpaying for strategic logic without adequately pricing execution complexity. A target may be strategically important, but if it requires regulatory concessions, local capital investment, management restructuring, technology integration, and cultural repair, the purchase price must reflect that burden.

A second mistake is underestimating optionality. Some cross-border deals create value not through immediate earnings contribution but through strategic positioning. A platform acquisition in a high-growth region may justify a premium if it creates future market access, supply-chain advantage, regulatory standing, or local credibility. The question is whether that option value is real and measurable.

Disciplined buyers separate strategic importance from strategic urgency. Urgency can justify action. It should not justify weak pricing.

The High-Conviction Opportunity Screen

In the current environment, acquirers need a sharper screen for identifying opportunities worth pursuing. A high-conviction cross-border deal should pass six tests.

The first test is strategic fit. The deal should advance a clearly defined corporate priority, not merely add geographic exposure. It should strengthen the company’s portfolio, capability base, market position, or supply-chain resilience.

The second test is control necessity. The buyer should understand why ownership is required. If a partnership, commercial agreement, minority stake, licensing structure, or joint venture can achieve the same objective with less risk, acquisition may not be the right path.

The third test is regulatory viability. The buyer should map foreign investment, antitrust, sanctions, export-control, data, labor, tax, and sector review issues before committing to the transaction.

The fourth test is valuation resilience. The deal should create value under conservative assumptions, not only under an optimistic synergy case. Buyers should stress-test exchange rates, financing costs, integration delays, demand weakness, regulatory remedies, and management attrition.

The fifth test is integration realism. The buyer should know what can be integrated globally and what must remain local. The integration model should reflect culture, regulation, systems, customers, and talent.

The sixth test is exit or adjustment flexibility. In volatile environments, acquirers should understand what happens if the market changes. Can the business be operated independently? Can the company sell noncore assets? Can it unwind parts of the strategy? Can it pause expansion without destroying value?

This screen helps prevent what often happens in competitive processes: the deal team becomes focused on winning the asset rather than owning it successfully.

Cross-Border Integration Is Not a Back-End Problem

The failure of many international deals begins before closing because integration is treated as a later-stage operational issue. In reality, integration should shape the transaction from the beginning.

Cross-border integration has four dimensions.

The first is cultural integration. Culture is not a soft issue. It affects speed, retention, customer trust, decision rights, risk tolerance, communication, accountability, and execution. A U.S. acquirer buying a European industrial company, a Japanese buyer acquiring a U.S. technology company, or a Gulf investor purchasing infrastructure assets in Europe will face different expectations around hierarchy, autonomy, governance, labor relations, and stakeholder management.

The second is regulatory integration. The buyer must understand which commitments, licenses, data restrictions, employee protections, foreign ownership rules, national security undertakings, and local governance requirements will remain after closing. Integration plans that ignore these constraints can violate approvals or damage local trust.

The third is systems integration. Data, cybersecurity, finance, ERP systems, compliance tools, reporting platforms, and customer databases often require careful sequencing. In regulated sectors, immediate integration may be impossible or undesirable. In technology deals, data transfer and access rights may be central to value creation but legally constrained.

The fourth is leadership integration. Cross-border deals depend heavily on local management. Buyers often underestimate the importance of retaining leaders who understand regulators, customers, labor dynamics, and informal market realities. Removing local leadership too quickly can destroy the asset’s value. Leaving leadership fully untouched can prevent integration. The right model is deliberate: retain local knowledge, clarify decision rights, and align incentives with the new strategic plan.

The integration question is not how fast the buyer can impose its operating model. It is which parts of the model should travel and which parts must adapt.

The Partnership Alternative

In a more scrutinized environment, full acquisition is not always the best strategy. Partnerships, minority investments, joint ventures, commercial alliances, licensing, distribution agreements, and structured options may offer better risk-adjusted access.

This is especially true in sensitive sectors or politically complex markets. A minority investment may give exposure without triggering the same level of control review. A joint venture may align with local policy priorities. A commercial partnership may test demand before capital commitment. A licensing arrangement may reduce operational burden. A staged acquisition may allow the buyer to increase ownership after regulatory or market milestones are met.

These structures are not risk-free. They create governance complexity, information-sharing issues, control limits, partner dependence, exit challenges, and potential antitrust concerns. But they can be valuable when full ownership would create excessive scrutiny or integration risk.

The strategic question is whether the company needs control immediately, eventually, or not at all.

Executives often prefer acquisition because it creates clarity. In cross-border strategy, clarity can be misleading. Ownership can create obligations that the company is not ready to manage. A well-designed partnership may create more strategic flexibility than a poorly integrated acquisition.

The Board’s Role in Cross-Border Deals

Boards should raise the standard for cross-border transaction approval. Directors should not merely review financial projections and fairness opinions. They should test the strategic and execution logic.

The first board question is why this deal, why this market, and why now. Management should be able to explain the strategic necessity clearly.

The second question is why acquisition rather than another structure. If control is required, management should explain why. If control is not required, the board should ask whether a lower-risk structure has been considered.

The third question is what could prevent closing. Regulatory, political, financing, shareholder, employee, or counterparty risks should be identified early.

The fourth question is what could prevent value creation after closing. Integration risk is often more important than signing risk.

The fifth question is how the valuation changes under stress. The board should review downside cases, not only base and upside cases.

The sixth question is who will own integration. The executive accountable for the deal should not disappear after closing. Ownership of synergies, talent, systems, compliance, and local relationships must be clear.

The seventh question is how the deal affects the company’s geopolitical exposure. A transaction may create new revenue but also new vulnerability. The board should understand both.

These questions do not slow good deals. They improve them.

The Cross-Border Deal Playbook

Companies should build a cross-border M&A playbook that reflects the current environment.

First, start with strategic priorities, not available targets. A company should know which capabilities, markets, technologies, or assets it needs before bankers present opportunities.

Second, map regulatory exposure before entering a process. National security, antitrust, data, sanctions, export controls, foreign subsidies, labor, tax, and sector approvals should be assessed early.

Third, build a bidder credibility strategy. Sellers increasingly value certainty. Buyers should be prepared to show that they understand the regulatory path and can close.

Fourth, design the transaction structure around risk. Full acquisition, staged acquisition, minority investment, joint venture, or partnership should be chosen deliberately.

Fifth, price uncertainty explicitly. Do not bury regulatory delay, currency exposure, integration cost, or remedy risk inside broad contingencies. Model them.

Sixth, align the public narrative with internal logic. Regulators, employees, customers, and investors will test whether the deal rationale is credible. Internal documents should not contradict external messaging.

Seventh, plan integration before signing. Cultural, regulatory, systems, and leadership integration should shape diligence and purchase agreements.

Eighth, preserve flexibility. Use earnouts, options, covenants, closing conditions, termination rights, indemnities, regulatory commitments, and staged capital deployment where appropriate.

Ninth, assign executive accountability. Every major cross-border deal should have a named executive owner responsible for value creation after close.

Tenth, review performance against deal thesis. Boards should revisit major transactions 12, 24, and 36 months after closing to assess whether assumptions held and whether integration delivered.

Discipline as Advantage

The next cross-border M&A cycle will not reward volume alone. It will reward discipline.

There will be attractive opportunities in 2026 and beyond. Companies will seek growth outside their home markets. Strategic buyers will pursue technology, infrastructure, energy assets, healthcare platforms, industrial capacity, and regional market access. Private capital will continue to look for deployment opportunities. Sellers will test the market as valuation conditions improve. UNCTAD has stated that FDI flows could increase modestly in 2026 if financing conditions continue to ease and cross-border M&A picks up, although real investment activity remains weighed down by geopolitical tensions and fragmentation.

But the environment will remain unforgiving. A deal that lacks regulatory foresight can fail before closing. A deal that ignores valuation discipline can destroy capital. A deal that underestimates integration can lose the very capabilities it sought to acquire. A deal that misunderstands local context can trigger political, cultural, or operational resistance.

The best acquirers will distinguish between activity and advantage. They will not chase every asset. They will identify where ownership matters, where partnerships are better, where valuation reflects risk, and where integration is realistic. They will treat national security and regulatory scrutiny as design constraints rather than obstacles discovered late. They will build deal teams that include strategy, legal, finance, integration, government affairs, tax, technology, and local leadership from the beginning.

Cross-border M&A remains one of the most powerful tools for strategic transformation. But in an era of heightened scrutiny, it must be practiced with greater rigor.

The companies that win will not be the ones that simply move fastest. They will be the ones that know when a deal is worth doing, how it can close, why it will create value, and what must be protected after ownership changes hands.